Researchers have gained new insights into largely overlooked circular RNAs in brain cells and the crucial role they play in diseases like Alzheimer’s and Parkinson’s. In addition to providing valuable ...

Biotechs in the charter city of Próspera aim to cure aging, but experts question the feasibility of their goals.

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...

The alliance announced Tuesday will span multiple programs in infectious diseases and cancer. Specific indications in those therapeutic areas were not disclosed, but Orna could earn up to $3.5 billion ...

CAMBRIDGE, Mass., May 16, 2022 /PRNewswire/ -- Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered circular RNA (oRNA) therapies, today for the first time announces ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

PRINCETON, N.J., Oct. 25, 2024 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics ...

A new set of strategies is being investigated to combat the coronavirus disease 2019 (COVID-19), as well as other future viral pandemics. This includes the use of novel antigens, adjuvants, and ...

Circular RNA (circRNA) is a unique type of non-coding RNA produced by back splicing of mRNA to form the covalent junction without 3’-5’ polarity and poly(A) tail. CircRNA was first discovered about 30 ...